Some providers escalate to 2mL weekly after four weeks if the patient tolerates the initial dose without gastrointestinal side effects (mild nausea, loose stools) and shows suboptimal fat loss velocity despite adherence to caloric targets
The program covers using these drugs to maintain weight loss, and your provider can attest that you met the BMI criteria at the time you first started therapy, even if that was before July 2026.participation, and whether you meet the eligibility requirements
[13] Overall, for the majority of users the side effects are mild and temporary, but anyone experiencing persistent or severe symptoms should seek medical attention
Get Answers Introduction to GLP-1 Glucagon-like peptide-1 (GLP-1) is a hormone that plays a crucial role in glucose metabolism and appetite regulation
It presents this as background for why the two medications are handled slightly differently when a week is missed
This includes people with stubborn fat deposits in the abdomen, hips, thighs, and arms